Dysimmune Diseases Foundation

About Dysimmune Diseases Foundation

A $250,000 grant to Tufts Medical Center in 2025 is the clearest marker of how the Dysimmune Diseases Foundation operates: it backs clinical and biomedical research on dysimmune and neuromuscular disorders with substantial awards to individual investigators and academic medical centers. The foundation’s recent grants show a pattern of repeated support to clinician-researchers, including Dr Shalini Mahajan, Dr Marinos Dalakas, and Dr Razzaq Ahmed, alongside institutional funding for medical centers and university-affiliated research programs. That mix points to a grantmaker focused on investigator-led work rather than broad general support. The foundation’s giving is tied to medical research at the level of principal investigators, clinics, and translational research settings. Awards also recur over multiple years, suggesting continuity with specific researchers and centers rather than one-off project sampling. Recent grants include support for Boston-area institutions and individual doctors in California, Maryland, and Massachusetts, reflecting a national reach with a relatively concentrated set of recipients. The grants cluster around autoimmune neuromuscular disease research, diagnosis, treatment, and related clinical work, including support for young investigators through a dedicated research program.

What Dysimmune Diseases Foundation Funds

The foundation’s cause areas are tightly centered on biomedical and clinical research into dysimmune and neuromuscular disease. In 2025, it gave $100,000 to Regents University of California in Oakland for medical research, and $75,000 to Regents of UC Irvine in Irvine for medical research, both pointing to academic research infrastructure as a key channel. It also supports physician-researchers pursuing disease-specific studies. The foundation awarded $96,000 in 2025 to Dr Marinos Dalakas in Potomac for medical research, continuing a multi-year line of support. Another example is Dr Thomas Branagan in Cortlandt Manor, who received $36,000 in 2025 for medical research. Clinical and clinic-linked work appears as well: in 2025, the foundation gave $37,500 to MGH - Down Syndrome Congress in Burlington for medical research and clinic. That mix of grants shows a narrow but multi-site emphasis on research, clinical investigation, and translational settings.

How Dysimmune Diseases Foundation Gives